12:00 AM
 | 
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Immunocore preclinical data

In a mouse xenograft model of melanoma, 0.01 mg/kg ImmTAC-MAGE given every other day for 10 doses significantly inhibited tumor growth at...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >